PURPOSE: Most successful treatment of the lung cancer patients is the surgical resection. Lung perfusion scintigraphy is established method in the complex pre-operative diagnostics of lung carcinoma. It is used for selection of candidates for surgical treatment and in determination of operability and in decision on the operation volume.
MATERIALS AND METHODS: We analyzed retrospectively the value of lung perfusion scintigraphy in 27 cases with primary lung carcinoma who had a lobectomy. Survival probability was calculated by Kaplan- Meier method. The log rank test was used to compare survival rates between groups.
RESULTS: All patients with lobectomy were staged pre-operatively by noninvasive procedures at stages I-IIIA. The lung perfusion scintigraphy demonstrated an enlarged mediastinum at 1 of the patients. Impaired perfusion in homolateral hilum and in the contralateral hilum was found in some of the patients. Changes in affected lung perfusion varied from impaired in different rate to perfusion defect. Perfusion indices at affected lung have mean=48,59%. The survival of patients with Perfusion index less than 49% was mean = 56,333 months, and median = 35 months (3 years). The survival of patients with Perfusion index more than 49% was mean = 99,214 months, and median = 64 months (5.3 years). For I and II stage mean survival time was 120,727 months, and median survival time was 112 months (9.3 years). For IIIA and IIIB stage mean survival time was 48,667 months, and median survival time was 29 months (2,4 years).
CONCLUSION: Lung perfusion scintigraphy is a valuable method in pre-operative diagnosis of lung carcinoma in determination of the extent of perfusion impairment in the affected lung and for determination of functional operability. Lobectomy is possible when perfusion in affected lung is over 41%, but the lower perfusion is not surely a contraindication for lobectomy. The extent of perfusion impairment is proportional to survival rate. Patients with lower perfusion impairments have more than 5 years median survival. In postoperative period perfusion scintigraphy shows re-distribution of perfusion in the healthy lung and in the rest of the operated lung. The survival of patients with lobectomy is corresponding to the clinical stage statistically significant.
Ali M.K., Mountain C.F., EwercM.S., et al. Predicting Loss of Pulmonary Function After Pulmonary Resection for Bronhogenic Carcinoma. Chest 1980: 77: 3: 337-342.
Chenuel B., Haouzi P., Oliver P., et al. Effect of exercise on lung perfusion scanning in patients with bronchogenic carcinoma.Eur Respir J 2002; 20:710-716.
Finakoshi Y., Takeda S. Sawabata N. et al. Long- Term Pulmonary Function after Lobectomy for Primary Lung Cancer. Asian Cardiovasc Thorac Ann 2005; 13: 311-315.
Golstraw P., Crowley J., Chansky K. et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage grouping in the forthcoming (seventh) edition of the TNM classification of malignant tumors. J Thorac Oncol 2007;2:706-714.
Giordano A., Calcagni M.L., Meduri G. et al. Perfusion Lung Scintigraphy for the Prediction of Postlobectomy Residual Pulmonary Function.Chest 1997; 111; 1542-1547.
Datta D, Lahiri B. Preoperative Evaluation of Patients Undergoing Lung Resection Surgery. Chest 2003, 123, 2096-2103.
Kim J-K , Jang S.H., Lee J.W. et al. Clinical parameters affecting prediction accuracy of postoperative lung function in non-small cell lung cancer. Interact Cardio Vasc Thorac Surg 2008;7:1019-1023.
Kristersson S., Lindell S-E., Svanberg L. Prediction of Pulmonary Functional Loss Due to Pneumonectomy Using 133Xe-Radiospirometry. Chest 1972; 62: 6: 694-698.
Kushibe K., Kawaguchi T., Kimura M. et al. Changes in ventilatory capacity, exercise capacity, and pulmonary blood flow after lobectomy in patients with lung cancer - which lobectomy has the most loss in exercise capacity? Interactive CardioVascular and Thoracic Surgery 2008, 7, 1011-1014.
Lefrak S.S. Preoperative Evaluation for Pulmonary Resection The Role of Radionuclide Lung Scanning. Chest 1977; 72: 4 : 419-420.
Levcheva V., Mluchkov M., Angelov V., Dzhambazov V., Chervenyakov A., Potential of perfusion scintigraphy to determine the volume of pathologic processes in the lungs. Symposium - Modern diagnostic and therapeutic methods in pneumology. Varna 16-17.10.1987, Abstr. p.16. (in Bulgarian)
Lütgemeier J., Kampman H., Konietzko N., Adam W.E. Lungendiagnostic mit Radionukliden. Gustav Fischer Verlag, Stuttgart-New York.1977.
Mountain CF. A New International Staging System for Lung Cancer. Chest 1986; 89: 225S-333S.
Nakahara K., Monden Y, Ohno K. et al. Prediction of lung cancer spread and functional resectability by 133Xe radiospirometry. The Japanese journal of surgery. 1985, 15, 4, 254-259.
Sando Y., Inoue T., Nadai R., Endo K. Ventilation/ perfusion ratios and simultaneous dual-radionuclide single-photon emission tomography with krypton-81m and technetium-99m macroaggregated albumin. Eur J Nucl Med 1997; 24: 10: 1237-1244.
Secker-Walker R.H.,Alderson P.O.,Wilhelm J. et al. Ventilation-Perfusion Scanning in Carcinoma of the Bronchus. Chest 1974; 65; 660-663.
Secker-Walker R.H., Provan J.L. Scintillation Scanning of Lungs in Preoperative Assessment of Carcinoma of Bronchus. Br. Med .J., 1969, 3, 327-330.
Svanberg.L. Regional Functional Decrease in Bronchial Carcinoma. Ann. Thorac. Surg. 1972: 13: 170-180.
Wernly J.A., DeMeester T.R, KirchnerP.T. et al. Clinical value of quantitative ventilation-perfusion lung scans in the surgical management of bronhogenic carcinoma. J. Thorac Cardiovasc Surg 1980;80; 535-543.
Zhu H., Zhao M., Liu C., Zhou J. Prediction of the postoperative pulmonary function in lung cancer patients with borderline function using ventilationperfusion scintigraphy. Nucl Med Commun 2012; 33:3: 283-287.
Von Beyer-Enke S.A., Clorius J., Becker H. et al. Synopsis von Computertomographie, Szintigraphye und Bronhoscopie bei der Diagnostik des Bronchialkarzinoms. RöFo, 1988; 149: 121-238.
Email this article (Login required) 
